Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2017-04-13 / Oncotarget 2017 Aug;8(32):52651-52664Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2017-03-22 / J Transl Med 2017 03;15(1):64Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2017-02-27 / Eur. J. Pharmacol. 2017 May;802:85-92Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2016-06-07 / Int J Hyperthermia 2016 09;32(6):648-56Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2016-04-27 / J. Pharmacol. Sci. 2016 Sep;132(1):24-30Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
/in Exosome, Hepatocellular Carcinoma, International Publications /von 2016-04-15 / Hepatology 2016 08;64(2):456-72Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-78Current status and perspectives of immune-based therapies for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-61A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-76
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de